Back to search

Peptide record

TPDB20411

Antibacterial Anticancer Hemolysis Toxicity standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20411
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia PD_Hemolysis
standard
No
A 30-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from Peptipedia and PD_Hemolysis, with an available 3D structural model.
Sequence
GLPVCGETCVGGTCNTPGCTCSWWPVCTRN
Physicochemical Analysis
C128H197N37O41S6
ADQHIKMFY
C
3102.56
5.90
1
1
6
-0
0.41
0.117
42.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
11375
366.63
14
Residue Composition
number
0
A
1
R
2
N
0
D
6
C
1
E
0
Q
5
G
0
H
0
I
1
L
0
K
0
M
0
F
3
P
1
S
5
T
2
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 1 N: 2 D: 0 C: 6 E: 1 Q: 0 G: 5 H: 0 I: 0 L: 1 K: 0 M: 0 F: 0 P: 3 S: 1 T: 5 W: 2 Y: 0 V: 3
Chemical Descriptors
30
C128H197N37O41S6
3102.56
5.90
-0
0.41
0.117
Evidence Records 4 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
14.0±0.7 µM
Hemolytic Cytotoxic
50% Hemolysis | 14.0±0.7 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting | Chembiochem | 2014
Evidence 2 Activity

Activity

50% Cell death
Toxicity
9.2±0.7 µM
Cytotoxic
50% Cell death | 9.2±0.7 | µM | target cell: Human foreskin fibroblasts (HFF)

Target

Human foreskin fibroblasts (HFF)

Source & Reference

NA
DBAASP
Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting | Chembiochem | 2014
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
50 %
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: 50% Hemolysis=14.0±0.7 µM | Cytotoxicity: HFF-1: CC50=9.2±0.7 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Chembiochem. 2014 Sep 5 15(13):1956-65.
Evidence 4 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis